Exercise Training to Atrial Fibrillation
ExAF
The Impact of Exercise Training to Patients With Atrial Fibrillation
1 other identifier
interventional
100
1 country
1
Brief Summary
To test the impacts of different exercise training programs to the cardiopulmonary function, muscle metabolism, and body mass composition
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable atrial-fibrillation
Started Nov 2021
Longer than P75 for not_applicable atrial-fibrillation
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 9, 2020
CompletedFirst Posted
Study publicly available on registry
August 11, 2020
CompletedStudy Start
First participant enrolled
November 3, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedAugust 19, 2025
August 1, 2025
3.2 years
August 9, 2020
August 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
AF burden
AF burden on 14 day ECG
5 months
CPET/6 minute walking test
CPET/6 minute walking test
5 months
DEXA/muscle MRI
DEXA/muscle MRI
5 months
Study Arms (3)
Aerobic training
EXPERIMENTALResistance training
ACTIVE COMPARATORControl
PLACEBO COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Paroxysmal or persistent atrial fibrillation
- Daily activity below moderate intensity \< 300 minutes or high intensity \< 150 minutes per week.
You may not qualify if:
- Active infection.
- Implant cardiac pacemaker.
- Uncontrolled hypertension.
- Cardiopulmonary contraindication to exercise training, such as decompensated heart failure, acute pulmonary edema, unstable angina, uncontrolled arrhythmia causing hemodynamic compromise, symptomatic severe aortic stenosis, suspected dissecting aortic aneurysm, severe pulmonary hypertension, acute myocarditis, endocarditis or pericarditis, uncontrolled asthma and SpO2 \< 90% at rest on room air.
- Inability to follow verbal command or to walk on treadmill or use stationary bike.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chih-Chieh Yu, MD.PhD
National Taiwan University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 9, 2020
First Posted
August 11, 2020
Study Start
November 3, 2021
Primary Completion
December 31, 2024
Study Completion (Estimated)
December 31, 2026
Last Updated
August 19, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share